The Company has proposed to subscribe 50.49% of the Equity Share Capital of TLL Parenterals Limited (CIN: U21001GJ2023PLC146963). Further details as per SEBI Regulations and Circulars are attached herewith.
Outcome Of Board Meeting
Filed with BSE · · 3 pages · English
Release
Later from Trident Lifeline
- Board Meeting Outcome for Outcome Of Board Meeting Held On November 26, 2024
- Announcement under Regulation 30 (LODR)-Acquisition
- Trident Lifeline Ltd. Press Release Nov 26 2024
- Announcement under Regulation 30 (LODR)-Updates on Acquisition
- Trident Lifeline Ltd. Press Release Dec 02 2024
Follow Trident Lifeline into a list and get an email when it puts out news.
Follow Trident Lifeline